AIMS: To investigate whether cannabis use predicted the first incidence of mood and anxiety disorders in adults during a 3-year follow-up period. DESIGN AND PARTICIPANTS: Data were derived from the Netherlands Mental Health Survey and Incidence Study (NEMESIS), a prospective study in the adult population of 18-64 years. The analysis was carried out on 3881 people who had no life-time mood disorders and on 3854 people who had no life-time anxiety disorders at baseline. MEASUREMENTS: Life-time cannabis use and DSM-III-R mood and anxiety disorders, assessed with the Composite International Diagnostic Interview (CIDI). FINDINGS: After adjustment for strong confounders, any use of cannabis at baseline predicted a modest increase in the risk of a first major depression (odds ratio 1.62; 95% confidence interval 1.06-2.48) and a stronger increase in the risk of a first bipolar disorder (odds ratio 4.98; 95% confidence interval 1.80-13.81). The risk of 'any mood disorder' was elevated for weekly and almost daily users but not for less frequent use patterns. However, dose-response relationships were less clear for major depression and bipolar disorder separately. None of the associations between cannabis use and anxiety disorders remained significant after adjustment for confounders. CONCLUSIONS: The associations between cannabis use and the first incidence of depression and bipolar disorder, which remained significant after adjustment for strong confounders, warrant research into the underlying mechanisms.
AIMS: To investigate whether cannabis use predicted the first incidence of mood and anxiety disorders in adults during a 3-year follow-up period. DESIGN AND PARTICIPANTS: Data were derived from the Netherlands Mental Health Survey and Incidence Study (NEMESIS), a prospective study in the adult population of 18-64 years. The analysis was carried out on 3881 people who had no life-time mood disorders and on 3854 people who had no life-time anxiety disorders at baseline. MEASUREMENTS: Life-time cannabis use and DSM-III-R mood and anxiety disorders, assessed with the Composite International Diagnostic Interview (CIDI). FINDINGS: After adjustment for strong confounders, any use of cannabis at baseline predicted a modest increase in the risk of a first major depression (odds ratio 1.62; 95% confidence interval 1.06-2.48) and a stronger increase in the risk of a first bipolar disorder (odds ratio 4.98; 95% confidence interval 1.80-13.81). The risk of 'any mood disorder' was elevated for weekly and almost daily users but not for less frequent use patterns. However, dose-response relationships were less clear for major depression and bipolar disorder separately. None of the associations between cannabis use and anxiety disorders remained significant after adjustment for confounders. CONCLUSIONS: The associations between cannabis use and the first incidence of depression and bipolar disorder, which remained significant after adjustment for strong confounders, warrant research into the underlying mechanisms.
Authors: Ron de Graaf; Mirjana Radovanovic; Margriet van Laar; Brian Fairman; Louisa Degenhardt; Sergio Aguilar-Gaxiola; Ronny Bruffaerts; Giovanni de Girolamo; John Fayyad; Oye Gureje; Josep Maria Haro; Yueqin Huang; Stanislav Kostychenko; Jean-Pierre Lépine; Herbert Matschinger; Maria Elena Medina Mora; Yehuda Neumark; Johan Ormel; Jose Posada-Villa; Dan J Stein; Hisateru Tachimori; J Elisabeth Wells; James C Anthony Journal: Am J Epidemiol Date: 2010-06-09 Impact factor: 4.897
Authors: Milena Radoman; Susanne S Hoeppner; Randi M Schuster; A Eden Evins; Jodi M Gilman Journal: Cogn Affect Behav Neurosci Date: 2019-08 Impact factor: 3.282
Authors: Natasha A Sokol; Cassandra A Okechukwu; Jarvis T Chen; S V Subramanian; Vaughan W Rees Journal: Am J Prev Med Date: 2018-09-24 Impact factor: 5.043
Authors: Anne Campbell; Steffani R Bailey; Kim A Hoffman; Javier Ponce-Terashima; Katie Fankhauser; Miguel Marino; Dennis McCarty Journal: J Psychoactive Drugs Date: 2020-04-15